Neuroluminary Survey Question Title * 1. What is your professional role or specialty? Neurologist Neurosurgeon Psychiatrist Neuroscientist (research) Neuropsychologist Other (please specify) Question Title * 2. What is your primary work setting? Academic research Clinical practice (hospital or private) Industry (e.g., pharmaceuticals, biotech) Government or policy Other (please specify) Question Title * 3. In which U.S. state do you primarily work? Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming Other (please specify) Question Title * 4. Which scientific discipline do you believe will experience the most growth and have the greatest impact on accelerating neuroscience discovery? Computational neuroscience / AI modeling Molecular biology and genetics Cognitive science and psychology Bioengineering / neural interfaces Pharmacology / drug development Other (please specify) Question Title * 5. What is the biggest barrier between neuroscience discoveries and their use in real-world treatments? Lack of funding for translational research Slow clinical trial processes Ethical and regulatory barriers Insufficient collaboration between researchers and clinicians Public misunderstanding of neuroscience Government interference or politicization of scientific research Other (please specify) Question Title * 6. Do you believe non-therapeutic brain enhancement (e.g., neurostimulation, memory drugs) should be allowed for healthy individuals? Yes – under regulation Yes – open to all No – only for diagnosed conditions No – ethically unacceptable Unsure Other (please specify) Question Title * 7. Do you think neuroscience will significantly improve our understanding of consciousness within the next 50 years? Definitely Probably Possibly Unlikely Never Other (please specify) Question Title * 8. Who should own brain data collected through wearables or implants? The patient or user The tech company The medical institution A shared public data bank Other (please specify) Question Title * 9. In what way do you believe CRISPR-based gene editing will most significantly impact neuroscience in the next 20 years? Treatment of monogenic neurological disorders (e.g., Huntington’s disease, Rett syndrome) Research models (e.g., creating animal models for neurodegenerative diseases) Neurodevelopmental disorder intervention (e.g., autism, intellectual disabilities) Neural regeneration or repair (e.g., post-stroke or spinal cord injury) CRISPR will have limited use in neuroscience due to ethical or delivery barriers Unsure Other (please specify) Question Title * 10. Do you believe advanced brain imaging will become a routine part of preventative healthcare in the future (e.g., early detection of mental illness, neurodegeneration, etc.)? Yes – and it will significantly improve early diagnosis and outcomes Yes – but only for high-risk populations Possibly – but it depends on cost and accessibility No – the science or practicality isn't there yet Unsure Other (please specify) Question Title * 11. Optional: If you would like is to share the outcomes of this survey, please provide your email. Question Title * 12. Optional: Any additonal thoughts, feeback, or comments are welcome. Thank you for your time and input. Done